BridgeBio Oncology Therapeutics, Inc.
BBOT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001869105
No open-market purchases or sales by BridgeBio Oncology Therapeutics, Inc. insiders were filed in the last 90 days; 65 institutions reported holding it in 13F filings for Q2 2026, worth $450.6M in total; no superinvestor holds it.
13F holders, Q1 2026
Institutional positions in BridgeBio Oncology Therapeutics, Inc. as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 67
- +17 vs. Q4 2025
- Shares held
- 57.4M
- +334.2K (+0.6%) vs. Q4 2025
- Total value
- $513.8M
- −$200.9M (−28.1%) vs. Q4 2025
- New holders
- 23
- 20 more added
- Sold out
- 6
- 11 more reduced
2 institutions that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BBOT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 65 | $450.6M |
| Q1 2026 | 67 | $513.8M |
| Q4 2025 | 52 | $724.7M |
| Q3 2025 | 42 | $657.5M |
| Q2 2025 | 34 | $177.6M |
| Q1 2025 | 31 | $186.3M |
| Q4 2024 | 32 | $172.7M |
| Q3 2024 | 31 | $171.1M |
| Q2 2024 | 31 | $167.4M |
| Q1 2024 | 29 | $166.9M |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2026
Shares, value and share of portfolio for each institution holding BridgeBio Oncology Therapeutics, Inc.; share changes are against Q4 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Cormorant Asset Management, LP | 17,878,594 | $160.0M | 8.07% | 00.0% | Unchanged |
| Deerfield Management Company, L.P. (Series C) | 4,885,446 | $43.7M | 0.52% | 00.0% | Unchanged |
| Omega Fund Management, LLC | 3,289,661 | $29.4M | 18.05% | 00.0% | Unchanged |
| EcoR1 Capital, LLC | 2,823,126 | $25.3M | 1.08% | 00.0% | Unchanged |
| Alphabet Inc. | 2,823,126 | $25.3M | 0.63% | 00.0% | Unchanged |
| Wellington Management Group LLP | 2,818,348 | $25.2M | 0.00% | −88,655−3.0% | Reduced |
| Enavate Sciences GP, LLC | 2,626,946 | $23.5M | 6.69% | 00.0% | Unchanged |
| Citadel Advisors LLC | 2,528,762 | $22.6M | 0.02% | −1,562−0.1% | Reduced |
| Novo Holdings A/S | 2,185,923 | $19.6M | 1.59% | +224,606+11.5% | Added |
| BlackRock, Inc. | 2,088,297 | $18.7M | 0.00% | +3,460+0.2% | Added |
| Laurion Capital Management LP | 1,922,656 | $17.2M | 1.61% | +457,718+31.2% | Added |
| Armistice Capital, LLC | 1,328,000 | $11.9M | 0.39% | +328,000+32.8% | Added |
| Aisling Capital Management LP | 1,018,018 | $9.11M | 1.91% | +453,393+80.3% | Added |
| Paradigm Biocapital Advisors LP | 868,213 | $7.77M | 0.16% | −1,393,536−61.6% | Reduced |
| Octagon Capital Advisors LP | 719,000 | $6.44M | 0.71% | −324,110−31.1% | Reduced |
| Royce & Associates LP | 636,522 | $5.70M | 0.06% | +636,522 | New |
| Geode Capital Management, LLC | 579,234 | $5.19M | 0.00% | +17,247+3.1% | Added |
| Vanguard Capital Management LLC | 538,441 | $4.82M | 0.00% | +538,441 | New |
| Eventide Asset Management, LLC | 541,181 | $4.70M | 0.08% | −541,181−50.0% | Reduced |
| Price T Rowe Associates Inc | 437,889 | $3.92M | 0.00% | −365,245−45.5% | Reduced |
| Adage Capital Partners GP, L.L.C. | 400,000 | $3.58M | 0.01% | −1,000,000−71.4% | Reduced |
| Ensign Peak Advisors, Inc | 320,874 | $2.87M | 0.01% | +320,874 | New |
| Charles Schwab Investment Management Inc | 290,806 | $2.60M | 0.00% | +11,760+4.2% | Added |
| Casdin Capital, LLC | 282,312 | $2.53M | 0.19% | 00.0% | Unchanged |
| Ikarian Capital, LLC | 270,231 | $2.42M | 0.35% | +50,000+22.7% | Added |
| Millennium Management LLC | 265,954 | $2.38M | 0.00% | +24,539+10.2% | Added |
| Vanguard Fiduciary Trust Co | 254,329 | $2.28M | 0.00% | +254,329 | New |
| Schroder Investment Management Group | 249,161 | $2.16M | 0.00% | +249,161 | New |
| FMR LLC | 240,300 | $2.15M | 0.00% | 00.0% | Unchanged |
| Granahan Investment Management Inc | 231,040 | $2.07M | 0.10% | +231,040 | New |
| State Street Corp | 226,278 | $2.03M | 0.00% | +8,000+3.7% | Added |
| Goldman Sachs Group Inc | 167,573 | $1.50M | 0.00% | +72,922+77.0% | Added |
| Sio Capital Management, LLC | 130,628 | $1.17M | 0.17% | 00.0% | Unchanged |
| Hudson Bay Capital Management LP | 110,000 | $984.5K | 0.01% | +110,000 | New |
| Woodline Partners LP | 103,707 | $928.2K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 102,258 | $915.2K | 0.00% | +44,224+76.2% | Added |
| Renaissance Technologies LLC | 101,900 | $912.0K | 0.00% | +27,600+37.1% | Added |
| Moore Capital Management, LP | 100,000 | $895.0K | 0.03% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 90,819 | $812.8K | 0.00% | +64,347+243.1% | Added |
| Toroso Investments, LLC | 82,172 | $735.4K | 0.00% | +82,172 | New |
| Tema ETFs LLC | 82,172 | $735.4K | 0.05% | +82,172 | New |
| Boothbay Fund Management, LLC | 80,884 | $723.9K | 0.02% | +13,850+20.7% | Added |
| HighVista Strategies LLC | 78,187 | $699.8K | 0.19% | −151,076−65.9% | Reduced |
| Qube Research & Technologies Ltd | 71,925 | $643.7K | 0.00% | +35,973+100.1% | Added |
| XTX Topco Ltd | 59,743 | $534.7K | 0.01% | +31,110+108.7% | Added |
| TD Asset Management Inc | 57,572 | $515.3K | 0.00% | −59,578−50.9% | Reduced |
| Opaleye Management Inc. | 53,282 | $476.9K | 0.06% | +53,282 | New |
| UBS Group AG | 50,450 | $451.5K | 0.00% | −42,919−46.0% | Reduced |
| ExodusPoint Capital Management, LP | 48,122 | $430.7K | 0.00% | +48,122 | New |
| Avidity Partners Management LP | 43,853 | $392.5K | 0.08% | +43,853 | New |
| Morgan Stanley | 43,374 | $388.2K | 0.00% | +29,022+202.2% | Added |
| Squarepoint Ops LLC | 43,190 | $386.6K | 0.00% | +31,675+275.1% | Added |
| Manufacturers Life Insurance Company, The | 35,692 | $319.4K | 0.00% | −18,500−34.1% | Reduced |
| Acadian Asset Management LLC | 29,148 | $260.0K | 0.00% | +29,148 | New |
| Vanguard Global Advisers, LLC | 18,163 | $162.6K | 0.00% | +18,163 | New |
| Axq Capital, LP | 17,347 | $155.3K | 0.02% | +17,347 | New |
| Diametric Capital, LP | 16,280 | $145.7K | 0.04% | +16,280 | New |
| Brevan Howard Capital Management LP | 14,248 | $127.5K | 0.00% | +14,248 | New |
| Quadrature Capital Ltd | 13,351 | $119.5K | 0.00% | +429+3.3% | Added |
| Aquatic Capital Management LLC | 11,793 | $105.5K | 0.00% | +11,793 | New |
| Bellevue Group AG | 6,982 | $62.5K | 0.00% | +6,982 | New |
| Rockefeller Capital Management L.P. | 700 | $6.26K | 0.00% | 00.0% | Unchanged |
| Accent Capital Management, LLC | 335 | $3.00K | 0.00% | +335 | New |
| Wells Fargo & Company | 300 | $2.69K | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 212 | $1.90K | 0.00% | +212 | New |
| Royal Bank of Canada | 154 | $1.00K | 0.00% | +154 | New |
| Caitong International Asset Management Co., Ltd | 4 | $36 | 0.00% | +4 | New |
| ADAR1 Capital Management, LLC | 0 | $0 | 0.00% | −226,248−100.0% | Sold out |
| StemPoint Capital LP | 0 | $0 | 0.00% | −86,517−100.0% | Sold out |
| BIT Capital GmbH | 0 | $0 | 0.00% | −25,000−100.0% | Sold out |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −23,584−100.0% | Sold out |
| Persistent Asset Partners Ltd | 0 | $0 | 0.00% | −8,585−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −3,990−100.0% | Sold out |
| Vanguard Group Inc | – | – | – | – | Not filed |
| CIBC Private Wealth Group, LLC | – | – | – | – | Not filed |